Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Hyperlipidaemia prevalenc… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Hyperlipidaemia prevalence and cholesterol control in obstructive sleep apnoea: Data from the European sleep apnea database (ESADA)

Artikel i vetenskaplig tidskrift
Författare C. Gunduz
O. K. Basoglu
Jan A Hedner
M. R. Bonsignore
H. Hein
R. Staats
I. Bouloukaki
G. Roisman
A. Pataka
P. Sliwinski
O. Ludka
J. L. Pepin
L. Grote
P. Steiropoulos
J. Verbraecken
E. Petiet
G. Trakada
J. M. Montserrat
I. Fietze
T. Penzel
L. Ondrej
D. Rodenstein
J. F. Masa
I. Bouloukaki
S. Schiza
B. Kent
W. T. McNicholas
S. Ryan
R. L. Riha
J. A. Kvamme
R. Schulz
L. Grote
J. Hedner
D. Zou
J. L. Pepina
P. Levy
S. Bailly
L. Lavie
P. Lavie
H. Hein
O. K. Basoglu
M. S. Tasbakan
G. Varoneckas
P. Joppa
R. Tkacova
R. Staats
F. Barbe
C. Lombardi
G. Parati
M. Drummond
M. van Zeller
M. R. Bonsignore
O. Marrone
M. Petitjean
G. Roisman
M. Pretl
A. Vitols
Z. Dogas
T. Galic
A. Pataka
U. Anttalainen
T. Saaresranta
R. Plywaczewski
P. Sliwinski
P. Bielicki
Col European Sleep Apnoea Database
Publicerad i Journal of Internal Medicine
ISSN 0954-6820
Publiceringsår 2019
Publicerad vid Institutionen för medicin
Språk en
Länkar dx.doi.org/10.1111/joim.12952
Ämnesord cholesterol, hyperlipidaemia, hypoxia, obesity, sleep apnoea, positive airway pressure, risk-factors, consequences, population, severity, obesity, disease, General & Internal Medicine
Ämneskategorier Klinisk medicin

Sammanfattning

Background and objective Obstructive sleep apnoea (OSA) and hyperlipidaemia are independent risk factors for cardiovascular disease. This study investigates the association between OSA and prevalence of hyperlipidaemia in patients of the European Sleep Apnea Database (ESADA) cohort. Methods The cross-sectional analysis included 11 892 patients (age 51.9 +/- 12.5 years, 70% male, body mass index (BMI) 31.3 +/- 6.6 kg/m(2), mean oxygen desaturation index (ODI) 23.7 +/- 25.5 events/h) investigated for OSA. The independent odds ratio (OR) for hyperlipidaemia in relation to measures of OSA (ODI, apnoea-hypopnoea index, mean and lowest oxygen saturation) was determined by means of general linear model analysis with adjustment for important confounders such as age, BMI, comorbidities and study site. Results Hyperlipidaemia prevalence increased from 15.1% in subjects without OSA to 26.1% in those with severe OSA, P < 0.001. Corresponding numbers in patients with diabetes were 8.5% and 41.5%, P < 0.001. Compared with ODI quartile I, patients in ODI quartiles II-IV had an adjusted OR (95% CI) of 1.33 (1.15-1.55), 1.37 (1.17-1.61) and 1.33 (1.12-1.58) (P < 0.001), respectively, for hyperlipidaemia. Obesity was defined as a significant risk factor for hyperlipidaemia. Subgroups of OSA patients with cardio-metabolic comorbidities demonstrated higher prevalence of HL. In addition, differences in hyperlipidaemia prevalence were reported in European geographical regions with the highest prevalence in Central Europe. Conclusion Obstructive sleep apnoea, in particular intermittent hypoxia, was independently associated with the prevalence of hyperlipidaemia diagnosis.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?